the Company: The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the for the Southern District of New York on behalf of investors who purchased TMS S.A. "or the "Company" /quotes/zigman/63594/delayed /quotes/nls/edap .68% securities between February 1, 2013 and July 30, 2014. , according to Market Watch. The complaint alleges that during the Class Period the Company made false and/or misleading statements regarding its Ablatherm-device. In particular it is alleged that the Company made false and/or misleading statements and/or failed to disclose that: a the Company overstated the efficacy and safety of its Ablatherm trials by relying on cross-study comparisons rather than a head-to-head trial; b the study survival endpoint was inappropriate for the patient populations; and c as a result of the aforementioned, the Company statements regarding its business and operations were materially false and misleading at all relevant times. NEW Aug 12, 2014 via - Click here to learn about the case: http://docs.wongesq.com/Info-Request-Form-350 . There is no cost or obligation to you.
(news.financializer.com). As
reported in the news.
Tagged under Southern District of New York, class action lawsuit topics.